Understanding the Types of Diabetes: Type 1, Type 2 & Gestational

Diabetes mellitus is a group of metabolic disorders characterized by chronic hyperglycemia. The three main types have distinct etiologies, pathophysiology, and management.

1. Type 1 Diabetes (T1D)

  • Cause: Autoimmune destruction of pancreatic β-cells → absolute insulin deficiency.
  • Onset: Typically childhood/adolescence, but can occur at any age (LADA in adults).
  • Prevalence: ~5–10% of diabetes cases.
  • Management: Lifelong exogenous insulin (multiple daily injections or pump), glucose monitoring (CGM preferred), carbohydrate counting, education. No insulin = diabetic ketoacidosis (DKA) → death.
  • Risk Factors: Genetics (HLA-DR3/DR4), family history, environmental triggers (viruses, early diet?). Not lifestyle-related.

2. Type 2 Diabetes (T2D)

  • Cause: Insulin resistance (muscle, liver, adipose) + progressive β-cell dysfunction → relative insulin deficiency.
  • Onset: Typically >40 years, but rising in youth due to obesity.
  • Prevalence: ~90–95% of cases.
  • Management: Lifestyle (diet, exercise, weight loss) → metformin first-line → add GLP-1 RA, SGLT2i, DPP-4i, TZD, SU, basal insulin per guidelines (ADA/EASD). Individualized HbA1c target (usually <7%).
  • Risk Factors: Obesity (esp. visceral), inactivity, family history, race/ethnicity, age, GDM history, PCOS, metabolic syndrome.

3. Gestational Diabetes Mellitus (GDM)

  • Cause: Placental hormones (hPL, cortisol, progesterone) induce insulin resistance in late pregnancy; β-cells cannot compensate sufficiently.
  • Screening: 24–28 weeks (1-step 75g OGTT or 2-step 50g screen → 100g OGTT).
  • Management: Medical nutrition therapy, glucose monitoring, exercise → insulin if targets not met (oral agents generally avoided in US).
  • Postpartum: Usually resolves, but 50% develop T2D within 10 years. Lifelong screening (1–3 years). Offspring at higher metabolic risk.

Other Types (Brief)

  • Monogenic (MODY, Neonatal): Single gene mutations; often misdiagnosed as T1/T2.
  • Pancreatogenic (Type 3c): Pancreatic disease (chronic pancreatitis, cystic fibrosis, resection).
  • Drug/Chemical-Induced: Glucocorticoids, antipsychotics, protease inhibitors, etc.

Accurate classification guides therapy, monitoring, and counseling. Autoantibody testing (GAD65, IA-2, ZnT8, IAA) and C-peptide help differentiate T1D from T2D/LADA when unclear.

Diabetes - Related Articles